Therapeutic potential of RNA interference against cancer (Q28253746)

Introduction of a Chimeric Chalcone Synthase Gene into Petunia Results in Reversible Co-Suppression of Homologous Genes in trans

Europe PubMed Central

title

Therapeutic potential of RNA interference against cancer (English)

0 references

1 reference

2

Takahiro Ochiya

0 references

author name string

Fumitaka Takeshita

series ordinal

1

0 references

language of work or name

English

0 references

publication date

August 2006

0 references

published in

Cancer Science

0 references

volume

97

0 references

issue

8

0 references

page(s)

689-96

0 references

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

A system for stable expression of short interfering RNAs in mammalian cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

The functions of animal microRNAs

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

MicroRNAs: genomics, biogenesis, mechanism, and function

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

Effective expression of small interfering RNA in human cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

Stable suppression of tumorigenicity by virus-mediated RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

Specific inhibition of bcr-abl gene expression by small interfering RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

RNA interference in adult mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

Enhancement of hypoxia-induced tumor cell death in vitro and radiation therapy in vivo by use of small interfering RNA targeted to hypoxia-inducible factor-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

Characterization of the bystander effect of somatostatin receptor sst2 after in vivo gene transfer into human pancreatic cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

Gene therapy for human small-cell lung carcinoma by inactivation of Skp-2 with virally mediated RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

Rad51 siRNA delivered by HVJ envelope vector enhances the anti-cancer effect of cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

Biomaterials for gene delivery: atelocollagen-mediated controlled release of molecular medicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

Atelocollagen for protein and gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

The role of atelocollagen-based cell transfection array in high-throughput screening of gene functions and in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

Antisense oligodeoxynucleotide against HST‐1/FGF‐4 suppresses tumorigenicity of an orthotopic model for human germ cell tumor in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

Role of interfacial hydrophobic residues in the stabilization of the leucine zipper structures of the transcription factors c-Fos and c-Jun

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

Potential of atelocollagen-mediated systemic antisense therapeutics for inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

Targeted conversion of the transthyretin gene in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X

In vivo monitoring of tumor relapse and metastasis using bioluminescent PC-3M-luc-C6 cells in murine models of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2006.00234.X